Archive for January, 2012

Actos Lawsuit Legal Scoop

Actos Lawsuit: To understand cancer, we must first understand nor­mal functioning of the body. The body is made up of billions of cells. Each organ of the body is made up of several different types of specialized cells. For example, the liver has cells that filter toxins from the blood, and the brain has nerve cells (called neurons) that are able to conduct electrical signals. Perhaps the most familiar cells are skin cells. Every flake of dry skin is made of millions of cells that are constantly dying and being replaced with new cells. The growth of new cells is care­fully balanced to occur at the same rate as the death of old cells. Your body has many mechanisms in place to regulate the timing of the birth and death of cells. Unfortunately, if one of these mechanisms malfunc­tions, the careful balance can be disrupted. Environ­mental toxins such as cigarette smoke, chemicals, and radiation can damage DNA and can disrupt these control mechanisms. A tumor may develop when new cells are created faster than old cells die. Tumors can be either benign or malignant. A benign tumor is an overgrowth of cells that is unchecked by the body’s normal mechanisms; thus, it will keep getting bigger. It is called benign because it does not cause you illness. Some benign tumors can get to be so large that they do cause problems, especially if they are in a confined space, such as your skull. A malignant tumor is also an overgrowth of cells.

You can live without a bladder. However, you still need something that can perform the two basic func­tions of the bladder: storing and emptying of urine. Physicians have come up with many ways over the years to accomplish these tasks, many of which are still used today. The simplest alternative is to place drainage tubes into the kidneys that come out through the skin and connect to bags on the abdomen. These tubes are known as nephrostomy tubes. Nephrostomy tubes are typically inserted into a person in the X-ray department by an interventional radiologist who uses some light sedation. For the patient, the bag provides an easy way to store urine and can be drained several times a day when convenient by opening a small valve on the bag.

For more information on Actos Lawsuit follow us on our RSS Feeds.

To provide a good long-term solution, surgeons most commonly use a portion of the small bowel to act as the new bladder. The identified piece of small bowel is removed from the main portion and is fashioned for its new use (see Question 79 for details). The urine that collects within this piece of bowel will ultimately be drained in one of three ways. First, the bowel can simply be left open at the skin for the urine to drain passively out into a bag that is attached to the abdomen. This type of drainage is known as a conduit, and the opening onto the skin is called a urostomy. Urine collects in the bag, which is then drained into a toilet several times each day. Second, the bowel can be sewn into a rough sphere con­nected to the skin by only a small, long channel. This channel prevents urine from leaking out but easily accommodates a small catheter. This is called a conti­nent urinary diversion. With this type of diversion, you must pass a catheter into the new bladder several times a day to drain the urine. This allows you to live without an ostomy bag, but for some patients, passing the catheter several times a day may be difficult or impossible. Third, the new bladder can be directly reattached to the urethra (called an orthotopic neobladder).

Information from other sources on Actos Lawsuit

Bladder cancer is a malignant overgrowth of the cells of the bladder. Most commonly, the growth occurs in cells that are in the urothelium. The lining of most hollow spaces in the body is made of epithelial cells. The lining of the inside of your cheek, for instance, is an epithelial cell lining. Also, the lining of your stomach, bowels, gallbladder, and—you guessed it—the bladder is made of epithelial cells. Each organ has its own subset of epithelial cells. In the bladder, the lining cells are called transitional epithelial cells. The cancer that grows from these cells is then called transitional cell cancer; 90% to 95% of all bladder cancers are of this type. If the cancer grows from a different type of cell in the bladder, it is given a different name. Other types of uncommon cancers in the bladder include squamous cell carcinoma and adenocarcinoma.

It is also possible that cancer in the bladder did not begin there but spread to the bladder from somewhere else. The bladder is an uncommon place for other tumors to “seed” (or metastasize), but it does occasionally occur. Although metastases are uncommon, tumors can occa­sionally grow directly into the bladder from an adjacent organ, such as the prostate, colon, rectum, or cervix. Bladder cancer is the fourth most common type of cancer in men and the eighth most common in women. The American Cancer Society estimated that in 2009, there would be about 70,980 new cases of bladder cancer diagnosed in the United States. In 2009, 14,330 deaths were expected from bladder cancer. In spite of the increased incidence of bladder cancer over the years, the rate of people dying from bladder cancer has decreased over the past 20 years.

Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Lawsuit visit our site often.

Actos Lawsuit

Actos Lawsuit Action

Actos Lawsuits : The stage is very important in determining the treatment that you will receive. There is a good barrier between the urothelium and the muscle of the bladder wall. If the tumor is kept within this barrier, the tumor can usually be completely removed with a transurethral resection of bladder tumor (TURBT) (Question 38). If the tumor has become more aggressive, it may figure out how to pass through this barrier. When the tumor has gotten through the protective layer, it becomes much more likely to spread outside of the bladder to other organs or lymph nodes. Once the tumor has gotten through the urothelium, simple scraping of the tumor is not likely to get all of the tumor out, and further therapy will be necessary—either surgery, chemotherapy, or radiation. The option that you and your doctor choose will depend on the extent of spread of the tumor and your overall health status.

Over the years, several different systems have been used to stage cancers. In an effort to ease confusion between different systems, doctors around the world met and decided to create a new staging system that would be relevant for all different types of cancer. This system is called TNM. The letters stand for Tumor size, lymph Node status, and the extent of Metastases.

For more information on Actos Lawsuits follow us on our RSS Feeds.

“Upper tract studies” are evaluations that your doctor does of your kidneys and ureters. The lining of the bladder is the urothelium. The same urothelium also lines the ureters and the inside of the kidneys. The kidneys and the ureters are then also potential locations of transitional cell cancer. The study that your doctor chooses depends on his or her personal opinion as well as the availability of each test at your hospital. Even if the upper tract study is negative, you will likely need to repeat the studies periodically. Patients with low-grade tumors have a low risk (approximately 2%) of developing upper tract tumors. The presence of a high-grade tumor or of diffuse carcinoma in situ, however, carries up to a 40% lifetime risk of developing an upper tract tumor.

Information from other sources on Actos Lawsuits

An ultrasound is often the easiest test to obtain and is therefore popular as a first study. Ultrasound technology generates sound waves and then measures their reflections off of internal structures to produce an image. The same imaging is used for obstetric ultrasounds to produce an image of the fetus. There is no radiation with an ultrasound. An ultrasound is very good for showing tumors and stones in the kidneys and for showing obstruction of the ureter causing hydronephrosis. It is not as good for showing small tumors inside the ureter or renal pelvis, and thus a second kind of study is usually needed in addition to the ultrasound.

Our use of the term or terms Actos Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Lawsuits visit our site often.

Actos Lawsuit

Actos Attorneys Resource

Actos Attorneys: When an individual has diffuse, high grade cancer of the bladder, even when superficial, bladder removal may be warranted. Many may have widespread carcinoma in situ (CIS) in conjunction with papillary disease. One can expect a high rate of recurrence and a high rate of progression to invasive disease. Generally, intravesical therapy is tried first. If this therapy is unsuccessful, repeated therapy or alternate intravesical therapies can be tried. However, with failure of intravesical therapy, further trials may prove to be equally ineffective and lead to unnecessary delay for potentially definitive curative therapy. Many recommend removal of the bladder if two courses of six weeks of BCG are ineffective. Therefore, radical cystectomy is a treatment option for any individual who is thought to be at significant risk for progression to musclc invasive and potentially metastatic disease.

For individuals with recurrent disease despite tumor removal and intravesical therapy, progression to a more serious, muscle invasive disease is common. The patient at high risk for progression must consider radical cystectomy. If the individual is not a candidate for radical cystectomy because of poor health or the individual refuses cystectomy, radiation therapy can be considered. There are no good studies available and it is difficult to assess the efficacy of radiation alone since it is always combined with TURBT and the completeness of tumor resection is an uncertain variable. In general, radiation plays a minimal role in the treatment of superficial bladder cancer.

For more information on Actos Attorneys follow us on our RSS Feeds.

For those individuals whose bladder tumors are at high risk for recurrence or progression, instillation of agents directly into the bladder can be worthwhile. The forms of therapeutic agents come in two groups: chemotherapy or immunotherapy. It is fortunate the bladder is readily accessible to these agents, allowing for direct action with minimal systemic side effects.

Those individuals at high risk for recurrence and or progression should be considered for this therapy. Individuals with multiple or diffuse superficial tumors, large tumors, high grade tumors, superficially invasive tumors, those with recurrence within one year, or individuals with CIS all should be considered for this treatment. In addition, those with positive cytology after resection or patients with persistent superficial tumors which could not be removed should also be considered.

Information from other sources on Actos Attorneys

The agent is passed via a catheter into the bladder. The passage of the catheter generally takes just a few seconds in a woman, and perhaps ten seconds in a man. The urethral meatus (the outermost part of the urethra) is first cleansed with an antiseptic solution and then the catheter, which is made slippery with a sterile lubricant, is inserted up the urethra and into the bladder. On passage of the catheter, there is minor, short lived discomfort which may be reduced by an injection up the urethra with numbing medication. The various therapeutic agents are not painful during the infusion but may cause side effects afterwards. Depending on the agent instilled, the patient is asked not to void for a period of time afterwards to allow the agent to have its maximal effect on the bladder lining.

BCG is a living but attenuated form of tuberculosis bacteria. Similar to other living vaccines, it is used to create a heightened immunity. There are a number of precautions which must be taken to make sure the BCG is infused safely. BCG should not be infused immediately or shortly after tumor resection. Several weeks should be allowed to pass so the BCG does not gain access into open blood vessels. In addition, BCG should not be infused if the individual has a urinary infection, has active bleeding, or if the catheterization is traumatic and causes bleeding. It should not be used in patients whose immune system is seriously compromised or for those on steroids, which can decrease the immune system.

Our use of the term or terms Actos Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Attorneys visit our site often.

Actos Attorneys

Actos Litigation Advice

Actos Litigation: A good starting point is your primary care physician. He will generally have a number of specialists to whom he generally refers his urology patients. If the primary care physician has been working with these urologists, he should have an appreciation of their skills and temperament. However, this does not mean he is referring you necessarily to the best available urologist in your area. His choices may be limited by insurance or hospital networks. An excellent source of information would be nurses who work in the operating room, recovery room or on the surgical floor where the urologist does his surgery. Asking friends or other individuals who have had experience with the urologist can also prove useful. After a little digging, you can often quickly learn what type of reputation the urologist has in the community. Generally, if an established urologist has a “good reputation” this is an indication that he has pleased many individuals with his care.

Given the litigious society we live in, most physicians can face at least one malpractice lawsuit during their careers. In urology, two of the most common causes of litigation would be a surgical mishap leading to a complication, or failure to diagnose cancer in a timely fashion.

Medicine is based on science, but also is an “art.” Individuals do not walk into their physicians offices with a diagnosis and treatment plan always readily apparent. Even the best intentioned, thorough physician will make mistakes. Most of these errors do not result in harm. On occasion they do, and a law suit may follow. If a physician develops a good working relationship with a patient, these bad outcomes more often than not are acknowledged and accepted without legal entanglement. Competent, busy physicians may be dealing with a higher mix of complicated patients, leading to a higher number of potential suits. Physicians who have poor “bed side manner” may find themselves dealing with more suits. If a physician has an inordinate number of suits, “red flags” should go up, as competency may be an issue.

For more information on Actos Litigation follow us on our RSS Feeds.

Medical information is scrutinized in journals and reviewed at conferences. The newest treatment regimens for advanced cancer are explored in clinical trials to determine their efficacy and safety. It is only after they are proven that they become adopted as standard practice by most physicians. For the vast majority of individuals with bladder cancer, excellent, comprehensive treatment can be obtained at the local level. For those requiring more specialized care or for those unfortunate individuals with advanced cancer who desire experimental therapy via a clinical trial for their cancer, a referral to the appropriate center may be appropriate.

Given the monetary pressures in today’s medical practice, some physicians are over booked and cannot see the allotted number of patients scheduled without delays. The theory behind this schedule is the expectation that a number of patients will not show for their appointment, allowing the physician to stay true to the schedule and not fall behind.

However, sometimes all of the patients do show, and the physician is delayed. Even with a carefully thought out schedule, emergencies may arise and some visits unexpectedly take longer than scheduled. The physician wants to devote the time and attention required for each individual. After all, you also expect the same time and attention during your visit. Even the most conscientious physician may find himself running behind in a busy medical practice. This lateness should be recognized by the physician who will often acknowledge it with an apology. If you find it distressing to wait more than fifteen minutes (a reasonable time to wait), you should discuss your feelings with your physician, who often can arrange an appointment at the beginning of the schedule when he will almost be guaranteed to be on time.

Information from other sources on Actos Litigation

You may need a second opinion if you are not doing well and your physician is unable to provide satisfactory explanations and solutions. Occasionally, your urologist may recommend a second opinion if your problem is unusual or particularly complicated. Having a physician you can trust is mandatory when dealing with cancer. Don’t let anyone pressure you into a second opinion if you feel confident in your physician’s abilities. On the other hand, if you are uncomfortable with your progress or a treatment recommendation, if you are not satisfied with the explanations given to you, don’t hesitate to seek out a second opinion. Your urologist should not feel threatened by this request as he wants you to feel comfortable with the plan of action. Only by partnering with your physician can he be most effective.

Cancer unfortunately is a common disease affecting almost all animals. People are equally susceptible; approximately one in three will be afflicted at some time in their life. In this chapter, we will review basic information regarding the bladder, bladder cancer, and cancer in general, including what causes it and some parameters used to determine how serious it is. A bladder stores urine and expels it at a convenient time. The bladder is a very useful organ, (tissues working together to accomplish a function), but an individual can live a normal life without one, if required, by surgical creation of a substitute. Bladder cancer can vary from the non serious, low grade superficial type (approximately 70%), to the invasive, aggressive type that can spread and prove to be fatal (approximately 30%). 5% of bladder cancer is accounted for by squamous cell carcinoma. This cancer is usually secondary to long term inflammation or infection of the bladder. Even rarer is adenocarcinoma, which accounts for less than 2% of all bladder cancers. More than 90% of bladder cancers arise from the lining bladder cells called transitional cells. Bladder cancer is almost always transitional cell cancer. These cells are also present in the urethra (the body tube which drains the bladder), as well as the renal pelvis (inner lining of the kidneys), and the ureters (the body tube draining the kidneys).

Our use of the term or terms Actos Litigation is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Litigation visit our site often.

Actos Litigation

Actos Cancer Data

Actos Cancer: This shift in treatment direction is a very important point and it can be confusing. On the one hand, your medi­cal team is still trying very actively to cure the cancer, if possible, and to prolong your life and improve its quality to the maximum extent. However, because the chance of cure is somewhat smaller, you and your medical team must also give thought to the benefits and drawbacks of treatment, to quality-of-life issues, and to making the decisions that make the most sense. You and your doctors will want to weigh the chance that treatment might be successful against the possible side effects, the time spent in treatment, and the possible limitations on your quality of life.

Your doctor may discover the metastasis during a rou­tine checkup, although sometimes a patient will experience symptoms. It might be bone pain, abdominal discomfort, severe headache, or tingling in the legs. (The latter may occur if a metastasis is pressing on nerves in the spine.) Per­haps you have lost weight without changing exercise or diet habits. A patient might develop a cough or abdominal pain, or experience hematuria (blood in the urine) or other symp­toms of bladder irritation.

For more information on Actos Cancer follow us on our RSS Feeds.

Any of these symptoms should send you to the phone to make an appointment with your doctors. They, in turn, will try to figure out if something sinister is beginning to occur. As you read this you might be thinking that if the cancer is so advanced-—-if it has spread to the lungs or bones—what’s the point of treating symptoms such as tingling in your legs or vague abdominal pain? Doctors take these symptoms seriously because even though the cancer has advanced and metastasized, you are likely to live for an extensive period of time—months or years-—-and it makes good sense to make sure that you are able to live that time as comfortably and as fully as pos­sible. If symptoms go untreated, your ability to participate in everyday life with your family and friends may be greatly diminished, and the time you have left with them may be cut short.

On the other hand, occasionally a specialist may decide to watch and wait. A doctor might make this choice, for example, when a change is seen on an X-ray but the patient is not experiencing any other symptoms. Or when a patient is unwell from other medical problems or is just keen to avoid treatment at that time. In such situations, sometimes the decision will be made to observe closely and start treat­ment when symptoms occur.

Information from other sources on Actos Cancer

What kind of treatment can a patient expect if the can­cer metastasizes? Surgery to remove the bladder is occasion­ally a possibility if the only site of recurrence is the bladder and surrounding tissues. It usually doesn’t make sense to operate if the cancer has spread to distant sites. Sometimes radiotherapy will be used to reduce the symptoms of recurrence in the bladder if the recurrence is too extensive to permit surgery or if distant metastases have also occurred. Chemotherapy is usually used if the cancer has spread widely or to distant sites, and radiotherapy is sometimes used for an isolated metastasis (for example, to the brain or to a bone). A palliative care specialist may be brought in for consultation on how to reduce your pain or make you more comfortable as your disease progresses. And your doctors may talk with you about participating in a clinical trial.

Our use of the term or terms Actos Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Cancer visit our site often.

Actos Cancer

Mesothelioma Lawyer Breaking News

Mesothelioma Lawyer : Simian virus 40, or SV40, is a virus that has been asso­ciated with the development of malignant mesothe­lioma. This virus is found in rhesus monkeys and is now widespread among humans. The way this virus was transferred from monkeys to humans is uncertain, but it is postulated that some of the transfer occurred from 1954 to 1963 through SV40-contaminated polio vaccines administered worldwide. Those people who received the injectable form of the polio vaccine are believed to be those at greatest risk. This vaccine doesn’t folly explain the transfer of this virus, because many humans who could not have received the contaminated vaccines are now infected with the SV40 virus. One theory that has been proposed is that the SV40 virus continues to be transferred from monkeys to humans or that humans can pass the virus from person to per­son. Propecia Lawsuit

For more information on Mesothelioma Lawyer follow us on our RSS Feeds.

The latter theory has been supported by data showing that SV40 can be excreted in human feces, breast milk, and semen. It is unlikely that this virus acts alone in the development of mesothelioma as most cancers have multiple risk factors associated with their development, and most mesotheliomas occur in asbestos exposed individuals. Instead, it is more likely that asbestos and SV40 may act together to develop into mesothelioma. Although rare, cases of mesothelioma have been found following radiation exposure to the chest and abdomen. These individuals were usually treated in the past with radiation therapy for a malignancy of the lymph glands known as lymphoma.

Lastly, there is an indication that a person’s own genes can play an important role in determining who is sus­ceptible, or vulnerable, to these mineral fibers and will then develop mesothelioma. It is hoped that doctors will be able to find the specific susceptibility gene in the future and that this may lead to the development of new prevention and treatment strategies to better control this disease. Exposure to asbestos is the link to the development of mesothelioma. People who end up with this disease usually have had some type of previous exposure to asbestos. How this works is not fully understood. It is thought that asbestos fibers are inhaled and first travel through the upper air passages, which include the throat, the trachea (windpipe), and the large bronchi (large breathing tubes of the lungs). These airways are lined with mucus, and therefore most of the fibers are cleared from these upper airways by sticking to this mucus and being coughed up or swallowed. When the fibers continue to travel and reach the small airways (the alveoli), the body’s immune system is able to sur­round, engulf, and remove the smaller fibers by a process known as phagocytosis. Actos Lawsuit

 

Information from other sources on Mesothelioma Lawyer

The large, long, thin fibers cannot be cleared as easily and may eventually reach the pleura (the lining of the lung and the chest wall), where they may irritate and injure the cells and lead to the development of calcium containing plate­like structures on the pleural lining (pleural plaques), fibrosis (scar tissue formation), or mesothelioma. These same asbestos fibers can also damage cells in the lung itself, which can lead to asbestosis (scar tissue in the lung) and/or lung cancer. Patients with these pleu­ral plaques seem to be at highest risk for developing mesothelioma.

The best way to prevent mesothelioma is to decrease one’s exposure to asbestos in the workplace, at home, and in the environment. The federal government is responsible for developing regulations that deal with asbestos exposure in the workplace. The agency that issues these regulations is known as the Occupational Safety and Health Administration (OSHA). Employ­ers are required to follow these regulations, and there­fore workers who are concerned about asbestos exposure should be discussing these concerns with their employers or union. Also, employees should be using all protective equipment provided to them by their employers and following recommended safety procedures and practices while at work.

Our use of the term or terms Mesothelioma Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Lawyer visit our site often.

Mesothelioma Lawyer

Actos and Bladder Cancer Process

Actos and Bladder Cancer : This is what is usually called a “false-positive” test result. The test was positive in a case where it seems that it should have been negative. Any medical test has a cer­tain false-positive rate (usually very low). The problem with a false-positive result with urine cytology is that there is no way to guarantee the absence of cancer. It is always possible that the cancer is there, but we have not been able to find it yet. Sometimes it can hide in places such as the ureters or kidney where we cannot see as well. Other times, especially with carcinoma in situ, the diseased areas look normal through the cysto- scope but actually harbor serious disease. Because of this, one should never ignore a positive cytology result. Close to 80% of patients with a positive cytology but a negative evaluation will eventually be found to have a urologic malignancy.

For more information on Actos and Bladder Cancer follow us on our RSS Feeds.

The current recommendation for patients with a posi­tive urine cytology and a negative initial evaluation is to repeat the urine cytology 6 to 8 weeks later. Those patients with a negative cytology on the follow-up test do not need further evaluation. If the follow-up cytol­ogy is positive, however, careful evaluation should be undertaken, as most of these patients will eventually be found to have a malignancy. Your urologist may rec­ommend multiple small biopsies of the bladder to look for carcinoma in situ, a condition that is often associ­ated with positive cytology.

Although cytology has long been the gold standard for bladder cancer screening, including monitoring for recur­rences, it is far from perfect (see Question 33), and there is great interest in finding an even better test. Currently, at least four other markers are approved by the Food and Drug Administration (FDA), although none of them are clearly better than cytology. In addition to these four, many new tests are being developed. The four listed here are those that are currently available to patients. If you are considering a radical cystec­tomy, you want an individual who regularly performs that operation. A radical cystectomy is a complicated, time-consuming procedure that some urologists rarely or never perform. The old dictum “practice makes perfect” certainly applies here. Furthermore, if you are interested in the neobladder option for reconstruction of your urinary tract, you should make sure that the urologist is comfortable with that portion of the oper­ation. The neobladder adds complexity to the proce­dure for the surgeon, and not all urologists are well trained in this area. The urologist should know his or her own complication rate for the procedure and not just quote widely published rates for other surgeons. He or she should be comfortable and willing to discuss these rates with you.

Information from other sources on Actos and Bladder Cancer

Cancer can be a frightening word and disease no matter how you look at it. You want a physician who understands your fears and concerns and who is willing to take the time to help you make your management decisions. There is no good measure for this, but trust your instincts at your first meeting with a new doctor. Sometimes you may feel that it is necessary to get a second opinion. You may have concerns about the treatment recommendations or may worry that there are other options that have not been presented. If you ever feel that you have not received enough informa­tion or that you are uncomfortable with the treatment recommendations from your urologist and/or oncolo­gist, then it is appropriate to seek a second opinion.

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

Actos and Bladder Cancer

Multaq and Liver Damage Information

Multaq and Liver Damage: The most effective treatment of chronic HCV is antiviral ther- apy—that is, medication that targets a virus. Interferon, a widely known antiviral discussed earlier in this chapter, is the treatment of choice for chronic HCV. Pegylated interferon in combination with ribavirin-—-the most common treatment-—is the most effective treatment for chronic hepatitis C, but the side effects can be substantial. Flulike symp­toms (fever, chills, muscle and joint pain, fatigue, weakness) are common, and doctors will prescribe medications to combat these symptoms if they become debilitating. It is also important for patients to maintain their activity levels to build a little muscle and be able to muster the energy to get through the day. Adequate fluid intake is also essential. This is a simple and often overlooked strategy. Many patients report that substantially increasing their daily fluid intake is the most effective method in combating the fiulike side effects that plague pegylated interferon therapy.

Depression, insomnia, irritability, and even confusion are expe­rienced by more than half of patients undergoing interferon ther­apy. The depression is considered to be somewhat different from classic major depression, but afflicted patients may benefit from a course of antidepressants such as citalopram (brand name Celexa) or sertraline (brand name Zoloft).

Other side effects that don’t seem to follow any regular pattern include headaches, vision problems or dry eyes, weight changes, brictle nails, insomnia, changes in blood levels, a burning sen­sation in the mouth (known as stomatitis), decreased sex drive, and menstrual irregularities. To some degree, these symptoms are manageable. But in some patients, the side effects can be severe, and supportive medications are able only to “take the edge off” Although treatment may be difficult, physicians who regularly treat chronic hepatitis C are well versed in managing side effects. Key to successful outcome is maintaining the proper dose of medication to ensure that patients have the best possible chance to permanendy rid their bodies of the virus.

For more information on Multaq and Liver Damage follow us on our RSS Feeds.

Because of chronic HCV’s complicated makeup—-the genotypes outlined above—pegylated interferon therapy must be custom­ized to each patient. Therapy duration is dictated by the genotype. Pegylated interferon is used, if possible, in combination with riba­virin. The only time ribavirin is not used is when there is a medical contra-indication, such as chronic kidney (renal) failure requiring dialysis or a severe allergy to ribavirin. How well the patient responds to antiviral treatment is determined by two simple lab tests. The first is the alanine transaminase (ALT) test. When the ALT decreases and returns to a normal level, it is referred to as a biochemical response. This does not always occur, but it is a con­sidered a good sign. The most important test in determining treat­ment success is the HCV RNA, or viral load test. The decline in the viral load is the most crucial aspect of therapy. Typically, a patient is tested at the outset, to determine a baseline or pre-treatment viral load, and then retested to measure against the subsequent viral loads as treatment progresses.

Four weeks after treat­ment begins, first viral load is measured. If a patient’s viral load is un-detectable at one month, the results are called a rapid virologie response, or RVR. People who achieve an RVR are called super responders. They have an excellent chance of eradicating the virus after they complete their treatment. A small subset of patients who achieve an RVR can sometimes stop treatment early. The deter­mination to stop treatment early is made on a case-by-case basis, and the patient should be informed of the pros (shorter treatment duration, lower cost, and less side effects) and cons (slightly lesser chance for sustained response) of this approach.

Information from other sources on Multaq and Liver Damage

After 12 weeks (three months) of therapy, viral load is mea­sured again. The outcome of this viral load test is referred to by different names, depending on the results. When the virus is unde­tectable after three months of therapy, the condition is described as a complete early virologie response (cEVR). If the viral load has declined by two logs but is still detectable, the data is referred to as a partial early virologic response (pEVR).

People who achieve a partial or complete early virologic response continue drug therapy. Those who do not achieve a two-log reduc­tion after 12 weeks are called nonresponders (NRs). Unfortunately, nonresponders have less than a 3 percent chance of achieving a sustained viral response even if they complete the full course of therapy. Therefore, therapy is stopped for nonresponders after three months if they do not obtain a two-log reduction.

For patients who remain on therapy, the next viral load test is taken after six months (24 weeks) of therapy. If this test indicates a detectable viral load, as a rule, treatment is stopped because these patients will not achieve treatment success even if they complete a full 48 weeks of therapy.

After 48 weeks of pegylated interferon and ribavirin, another viral load test is performed. Referred to as the end-of-treatment response (ETR), this viral load measurement marks the end of therapy and the beginning of a waiting game. For treatment to be considered a success, the viral load must remain negative for at least six months after the end of therapy. Unfortunately, some patients relapse and test positive during this six-month period. Relapsers should follow up and discuss their situation with a hepatologist and consider options such as enrollment in research clinical trials of new and experimental therapies can be considered.

Our use of the term or terms Multaq and Liver Damage is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq and Liver Damage visit our site often.

Multaq and Liver Damage

Multaq Lawyer Info

Multaq Lawyer: Although no treatment exists for HAV, it is important to treat the symptoms. Patients experiencing fatigue should rest and not to push themselves. All HAV patients must drink plenty of fluids because dehydration can easily develop as a complication, espe­cially if the patient has had diarrhea. The good news about HAV is that if a person receives the proper vaccine series, the disease is almost always preventable. The HAV vaccine series has been used extensively worldwide and has proved to be a safe and extremely effective vaccine.

The first hepatitis virus to be discovered, hepatitis B (HBV), has infected an estimated 2 billion people worldwide. About 300 million are chronic carriers of the virus, including about 1.25 million Americans. HBV can be deadly; its complications kill about 1 million people every year, and it is the most prevalent cause of cirrhosis and liver cancer in the world, particularly in Africa and Southeast Asia. Yet most people infected with HBV lead fully normal lives.

The HBV virus can be found in body fluids, including saliva, blood, tears, and breast milk, though it is transferred between people only through blood and semen. Casual contact, such as hugging or shaking hands, does not spread the disease; in fact, not everyone infected with HBV is contagious. HBV can be con­tracted only through sexual contact, a blood exchange, or from a pregnant mother to her fetus—a method of transmission common in Africa and Asia.

For more information on Multaq Lawyer follow us on our RSS Feeds.

Before 1975, blood and platelets collected from blood donors (during blood drives, for example) were not screened for HBV so transfusions once accounted for many HBV infections in this country. Today, donated blood is tested for HBV, but the virus continues to be transferred through more subtle blood exchanges, such as when an infected person shares a razor or nail clippers, or exposes another person through a bleeding skin condition.

Needles used for tattooing and acupuncture can also be contaminated with blood infected with HBV. People diagnosed with hepatitis B need to take special care to cover any bleeding spots, and everyone should avoid contact with used needles. The HBV virus can live on an open surface, including needles, for up to a week.

Immunization is key to preventing hepatitis B. People who have been vaccinated are virtually 100 percent protected, so HBV is a disease that could be eliminated. For now, though, its important for individuals at risk to take precautions. Health-care workers, any­one who received a blood transfusion before 1975, and anyone who lives with (or is sexually intimate with) an HBV-infected person are candidates for screening. In fact, it is recommended that sexually active homosexual men, intravenous drug users, dialysis patients, and anyone who has more than one sex partner within six months be screened for HBV. Anyone who receives results that indicate he or she is not immune should receive the vaccine series.

Information from other sources on Multaq Lawyer

Acute hepatitis B, or HBV that lasts less than six months, is no longer prevalent in the United States, probably the result of early vaccinations. It does occasionally occur, however, and its flulike symptoms—fever, abdominal upset, nausea, decreased appetite, vomiting, and changes in the way things taste and smell—resem­ble symptoms associated with other hepatitis infections. In some cases, the individual experiences symptoms that make it clear the immune system is fighting off the HBV, such as muscle and joint aches, too much protein in the urine, or a rash.

Our use of the term or terms Multaq Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawyer visit our site often.

Multaq Lawyer

Actos Lawyer Headlines

Actos Lawyer: The medical history of those with bladder cancer varies. For many patients, the first clue is blood in the urine, while in others, it may be an alteration in urination. Sometimes a tumor is found inadvertently on an X ray or ultrasound exam. In all cases, an initial assessment is implemented by the urologist. In this chapter, we will review the presenting findings of those with bladder cancer and how they are initially “worked up.” A sign is a physical finding from an underlying disease or disorder which can be noted by the individual or the physician. A symptom is something the individual feels or experiences from a disease. A clinical sign is a physical finding, while a symptom is something the individual experiences.

For more information on Actos Lawyer follow us on our RSS Feeds.

Absolutely! Approximately three quarters of individuals with bladder cancer initially present with blood in their urine. The blood may be visible to the naked eye (gross hematuria), or seen with a microscope only (microscopic hematuria). In the case of gross hematuria secondary to bladder cancer, it is often total (throughout the entire stream) and may be intermittent. Generally, there is no pain associated with it. I have seen many patients over the years who had gross hematuria months earlier who falsely assumed their condition was not serious since the bleeding stopped and there was no pain, only to come in later with recurrent bleeding, their tumors needlessly more advanced. When an individual experiences gross hematuria, a work up is a must! Gross hematuria at times can become quite severe to the point blood clots can restrict the flow of urine. What could have been an elective assessment then becomes a mad dash to the emergency room for catheterization (passing a tube into the bladder) and irrigation or an emergency procedure. Of course, there are other causes for gross hematuria, such as urinary infections, kidney stones or tumors in the kidney, all of which require assessment.

Information from other sources on Actos Lawyer

If a urine dipstick is positive for blood, it is recommended to check the urine under a microscope. The urine is first spun down to separate out the sediment and is then examined under the high power lens. If there are more than 3 red blood cells per high power field it is felt to be significant. If there are no other reasons for the presence of blood such as a urinary infection, the urine should be rechecked. If there is a persistent presence of significant microscopic hematuria, an assessment is recommended. When there is a large amount of microscopic hematuria, especially in older individuals with risk factors for bladder cancer, there is no need to repeat the urinalysis as a workup should be done.

A small amount of microscopic hematuria in an individual without symptoms (asymptomatic microscopic hematuria) can be found in many healthy individuals. It has been estimated that up to 10% of the population has asymptomatic microscopic hematuria. In brief, the older you are (generally over the age of 40), the more risk factors you have (smoking, occupational exposure), and the more red blood cells present, the more likely serious pathology (disease of the urinary tract including bladder cancer) will be found. If you have persistent microscopic hematuria without a known cause, a urologic assessment is recommended.

Our use of the term or terms Actos Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Lawyer visit our site often.

Actos Lawyer